Spots Global Cancer Trial Database for Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.
Official Title: A Randomized, Double-blind, Placebo-Controlled, Dose Response Study to Evaluate 851B Gel Delivered Intravaginally Twice a Week for Two, Three-Week Cycles in Women Who Are Positive For High-Risk Genotypes of Human Papillomavirus and Have Mild Cytological Abnormalities
Study ID: NCT00117884
Conditions
Study Description
Brief Summary: The purpose of this study was to evaluate efficacy of 851B gel over a range of concentrations and dosing regimens on high-risk cervical human papillomavirus infection in women.
Detailed Description: Cervical cancer is caused by infection with specific genotypes of the human papillomavirus referred to as oncogenic or high-risk human papillomavirus. Current epidemiologic evidence suggests that 80% of sexually active women will become infected during their lifetime with human papillomavirus and 50% of these infections will be due to high-risk human papillomavirus. With US annual rates of cervical cancer now in the range of 13,000/year, a very substantial number of women are left with uncertainty regarding whether their infection will clear spontaneously or progress to cancer. Subjects participating in this study were required to visit the clinic for approximately 15 or 16 visits, and maintain a diary of self-dosing and menstruation cycles. The total time of participation in this study was approximately 27 months.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
, Colton, California, United States
, San Diego, California, United States
, Colorado Springs, Colorado, United States
, Boynton Beach, Florida, United States
, Tampa, Florida, United States
, Augusta, Georgia, United States
, Savannah, Georgia, United States
, Louisville, Kentucky, United States
, Detroit, Michigan, United States
, Moorestown, New Jersey, United States
, New York, New York, United States
, Charlotte, North Carolina, United States
, Winston-Salem, North Carolina, United States
, Oklahoma City, Oklahoma, United States
, Pittsburgh, Pennsylvania, United States
, Nashville, Tennessee, United States
, Arlington, Texas, United States
, Austin, Texas, United States
, Houston, Texas, United States
, Renton, Washington, United States
, Seattle, Washington, United States
, Spokane, Washington, United States
, Quebec, , Canada
Contact Details
Name: Medical Director
Affiliation: Takeda
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
